Related references
Note: Only part of the references are listed.Folic Acid-Functionalized Metal-Organic Framework Nanoparticles as Drug Carriers Improved Bufalin Antitumor Activity Against Breast Cancer
Hairong Zeng et al.
FRONTIERS IN PHARMACOLOGY (2022)
Research Progress in Pharmacological Activities and Applications of Cardiotonic Steroids
Junwei Ren et al.
FRONTIERS IN PHARMACOLOGY (2022)
Bufalin stimulates antitumor immune response by driving tumor-infiltrating macrophage toward M1 phenotype in hepatocellular carcinoma
Zhuo Yu et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)
Novel Strategies for Solubility and Bioavailability Enhancement of Bufadienolides
Huili Shao et al.
MOLECULES (2022)
Bufalin inhibits ovarian carcinoma via targeting mTOR/HIF-α pathway
Shan Su et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2021)
Steroid receptor coactivator-1 enhances the stemness of glioblastoma by activating long noncoding RNA XIST/miR-152/KLF4 pathway
Miaomiao Gong et al.
CANCER SCIENCE (2021)
Design of dual targeting immunomicelles loaded with bufalin and study of their anti-tumor effect on liver cancer
Hao Gou et al.
JOURNAL OF INTEGRATIVE MEDICINE-JIM (2021)
Bufalin enhances the killing efficacy of NK cells against hepatocellular carcinoma by inhibiting MICA shedding
Rao Fu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2021)
Co-delivery of bufalin and nintedanib via albumin sub-microspheres for synergistic cancer therapy
Ying Xu et al.
JOURNAL OF CONTROLLED RELEASE (2021)
Bufalin inhibits the malignant development of non-small cell lung cancer by mediating the circ_0046264/miR-522-3p axis
Jing Jin et al.
BIOTECHNOLOGY LETTERS (2021)
Tumor-Targeted Delivery of Bufalin-Loaded Modified Albumin-Polymer Hybrid for Enhanced Antitumor Therapy and Attenuated Hemolysis Toxicity and Cardiotoxicity
Ying Xu et al.
AAPS PHARMSCITECH (2021)
Toad venom: A comprehensive review of chemical constituents, anticancer activities, and mechanisms
Fang-Jie Li et al.
ARCHIV DER PHARMAZIE (2021)
Bufalin targets the SRC-3/MIF pathway in chemoresistant cells to regulate M2 macrophage polarization in colorectal cancer
Jinbao Chen et al.
CANCER LETTERS (2021)
Na+/K+-ATPase Revisited: On Its Mechanism of Action, Role in Cancer, and Activity Modulation
Jiri Bejcek et al.
MOLECULES (2021)
Therapeutic potential of targeting membrane-spanning proteoglycan SDC4 in hepatocellular carcinoma
Heng Yang et al.
CELL DEATH & DISEASE (2021)
Bufalin induces mitochondrial dysfunction and promotes apoptosis of glioma cells by regulating Annexin A2 and DRP1 protein expression
Yao Li et al.
CANCER CELL INTERNATIONAL (2021)
Bufalin suppresses tumour microenvironment-mediated angiogenesis by inhibiting the STAT3 signalling pathway
Kai Fang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2021)
Clinical efficacy and safety of Huachansu injection combination with platinum-based chemotherapy for advanced non-small cell lung cancer A systematic review and meta-analysis of randomized controlled trials
Xinmei Tan et al.
MEDICINE (2021)
Effects of low-dose bufalin combined with hydroxycamptothecin on human castration-resistant prostate cancer xenografts in nude mice
Renze Gu et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2021)
Bufalin inhibits human diffuse large B-cell lymphoma tumorigenesis by inducing cell death through the Ca2+/NFATC1/cMYC pathway
Jincheng Song et al.
CARCINOGENESIS (2021)
Acetyl-bufalin shows potent efficacy against non-small-cell lung cancer by targeting the CDK9/STAT3 signalling pathway
Lehe Yang et al.
BRITISH JOURNAL OF CANCER (2021)
Bufalin reverses multidrug resistance by regulating stemness through the CD133/nuclear factor-kappa B/MDR1 pathway in colorectal cancer
Zhan Yueping et al.
CANCER SCIENCE (2020)
Global Metabolomic and Lipidomic Analysis Reveal the Synergistic Effect of Bufalin in Combination with Cinobufagin against HepG2 Cells
Jinghui Zhang et al.
JOURNAL OF PROTEOME RESEARCH (2020)
Determination of Endogenous Bufalin in Serum of Patients With Hepatocellular Carcinoma Based on HPLC-MS/MS
Mengfei Han et al.
FRONTIERS IN ONCOLOGY (2020)
Bufalin down-regulates Axl expression to inhibit cell proliferation and induce apoptosis in non-small-cell lung cancer cells
Nam-Yi Kim et al.
BIOSCIENCE REPORTS (2020)
Bufalin Induces Glioma Cell Death by Apoptosis or Necroptosis
Hai Rui LingHu et al.
OncoTargets and Therapy (2020)
Silencing c-Myc Enhances the Antitumor Activity of Bufalin by Suppressing the HIF-1α/SDF-1/CXCR4 Pathway in Pancreatic Cancer Cells
Xia Liu et al.
FRONTIERS IN PHARMACOLOGY (2020)
Molecular mechanisms of bufadienolides and their novel strategies for cancer treatment
Li-Juan Deng et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Albumin coated trimethyl chitosan-based targeting delivery platform for photothermal/chemo-synergistic cancer therapy
Haiyan Hu et al.
CARBOHYDRATE POLYMERS (2020)
Identification of Cardiac Glycosides as Novel Inhibitors of eIF4A1-Mediated Translation in Triple-Negative Breast Cancer Cells
Cory M. Howard et al.
CANCERS (2020)
Toad Venom Antiproliferative Activities on Metastatic Melanoma: Bio-Guided Fractionation and Screening of the Compounds of Two Different Venoms
Laura Soumoy et al.
BIOLOGY-BASEL (2020)
Bufalin inhibits hepatitis B virus-associated hepatocellular carcinoma development through androgen receptor dephosphorylation and cell cycle-related kinase degradation
Zhuo Yu et al.
CELLULAR ONCOLOGY (2020)
Bufalin exerts antitumor effects in neuroblastoma via the induction of reactive oxygen species-mediated apoptosis by targeting the electron transport chain
Lijia Pan et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2020)
Bufalin attenuates triple-negative breast cancer cell stemness by inhibiting the expression of SOX2/OCT4
Fei Chen et al.
ONCOLOGY LETTERS (2020)
Anti-tumor Activity of Bufalin by Inhibiting c-MET Mediated MEK/ERK and PI3K/AKT Signaling Pathways in Gallbladder Cancer
Liqiang Qian et al.
JOURNAL OF CANCER (2020)
Bufalin Induces Apoptosis and Improves the Sensitivity of Human Glioma Stem-Like Cells to Temozolamide
Jia Liu et al.
ONCOLOGY RESEARCH (2019)
Bufalin engages in RIP1-dependent and ROS-dependent programmed necroptosis in breast cancer cells by targeting the RIP1/RIP3/PGAM5 pathway
Yanlan Li et al.
ANTI-CANCER DRUGS (2019)
The sodium pump α1 subunit regulates bufalin sensitivity of human glioblastoma cells through the p53 signaling pathway
Yu-Long Lan et al.
CELL BIOLOGY AND TOXICOLOGY (2019)
Bufalin induces apoptosis via mitochondrial ROS-mediated caspase-3 activation in HCT-116 and SW620 human colon cancer cells
Di Wu et al.
DRUG AND CHEMICAL TOXICOLOGY (2019)
A review of cardiac glycosides: Structure, toxicokinetics, clinical signs, diagnosis and antineoplastic potential
Ana Flavia M. Botelho et al.
TOXICON (2019)
High-intensity focused ultrasound enhances the effect of bufalin by inducing apoptosis in pancreatic cancer cells
Zhouyu Ning et al.
ONCOTARGETS AND THERAPY (2019)
Bufalin suppresses the migration and invasion of prostate cancer cells through HOTAIR, the sponge of miR-520b
Jian-jun Zhang et al.
ACTA PHARMACOLOGICA SINICA (2019)
New therapeutic aspects of steroidal cardiac glycosides: the anticancer properties of Huachansu and its main active constituent Bufalin
Chien-shan Cheng et al.
CANCER CELL INTERNATIONAL (2019)
The Na+K+-ATPase Inhibitor Marinobufagenin and Early Cardiovascular Risk in Humans: a Review of Recent Evidence
Michel Strauss et al.
CURRENT HYPERTENSION REPORTS (2019)
Platelet-membrane-biomimetic nanoparticles for targeted antitumor drug delivery
Haijun Wang et al.
JOURNAL OF NANOBIOTECHNOLOGY (2019)
Bufalin-Loaded PEGylated Liposomes: Antitumor Efficacy, Acute Toxicity, and Tissue Distribution
Jiani Yuan et al.
NANOSCALE RESEARCH LETTERS (2019)
Bufalin, a Traditional Chinese Medicine Compound, Prevents Tumor Formation in Two Murine Models of Colorectal Cancer
Xiao Sun et al.
CANCER PREVENTION RESEARCH (2019)
Degradation of MCL-1 by bufalin reverses acquired resistance to osimertinib in EGFR-mutant lung cancer
Fei Cao et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2019)
Cytotoxicity and antimitotic activity of Rhinella schneideri and Rhinella marina venoms
Sara Abdelfatah et al.
JOURNAL OF ETHNOPHARMACOLOGY (2019)
Bufalin Induces Apoptotic Cell Death in Human Nasopharyngeal Carcinoma Cells through Mitochondrial ROS and TRAIL Pathways
En-Yun Su et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2019)
Bufalin induces protective autophagy by Cbl-b regulating mTOR and ERK signaling pathways in gastric cancer cells
Hai-Yan Qi et al.
CELL BIOLOGY INTERNATIONAL (2019)
Magnetic iron oxide nanoparticles for drug delivery: applications and characteristics
Thomas Vangijzegem et al.
EXPERT OPINION ON DRUG DELIVERY (2019)
Bufalin-Loaded CaP/DPPE-PEG-EGF Nanospheres: Preparation, Cellular Uptake, Distribution, and Anti-Tumor Effects
Jie Xu et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2019)
Endogenous Bufadienolides, Fibrosis and Preeclampsia
Vitaliy A. Reznik et al.
CARDIOLOGY RESEARCH AND PRACTICE (2019)
Bufalin inhibits glioblastoma growth by promoting proteasomal degradation of the Na+/K+-ATPase α1 subunit
Yu-Long Lan et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Bufalin inhibits human breast cancer tumorigenesis by inducing cell death through the ROS-mediated RIP1/RIP3/PARP-1 pathways
Yanlan Li et al.
CARCINOGENESIS (2018)
Cardiac glycoside bufalin blocks cancer cell growth by inhibition of Aurora A and Aurora B activation via PI3K-Akt pathway
Chuan-Ming Xie et al.
Oncotarget (2018)
Bufalin inhibits gastric cancer invasion and metastasis by down-regulating Wnt/ASCL2 expression
Jie Wang et al.
Oncotarget (2018)
Bufalin suppresses hepatocarcinogenesis by targeting β-catenin/TCF signaling via cell cycle-related kinase
Zhuo Yu et al.
SCIENTIFIC REPORTS (2018)
Bufalin inhibits cell proliferation and migration of hepatocellular carcinoma cells via APOBEC3F induced intestinal immune network for IgA production signaling pathway
Zongguo Yang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
BF211, a derivative of bufalin, enhances the cytocidal effects in multiple myeloma cells by inhibiting the IL-6/JAK2/STAT3 pathway
Xiao-yu Wu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
Role of P53-Senescence Induction in Suppression of LNCaP Prostate Cancer Growth by Cardiotonic Compound Bufalin
Yong Zhang et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Clinical practice guidelines for the treatment of primary liver cancer with integrative traditional Chinese and Western medicine
Chang-quan Ling et al.
JOURNAL OF INTEGRATIVE MEDICINE-JIM (2018)
Bufalin induces apoptosis in vitro and has Antitumor activity against human lung cancer xenografts in vivo
Shin-Hwar Wu et al.
ENVIRONMENTAL TOXICOLOGY (2017)
Effects of bufalin on the mTOR/p70S6K pathway and apoptosis in esophageal squamous cell carcinoma in nude mice
Yao Liu et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2017)
Folate receptor targeted bufalin/β-cyclodextrin supramolecular inclusion complex for enhanced solubility and anti-tumor efficiency of bufalin
Zou Aihua et al.
MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2017)
Bufalin induced apoptosis in SCC-4 human tongue cancer cells by decreasing Bcl-2 and increasing Bax expression via the mitochondria-dependent pathway
Han-Yu Chou et al.
MOLECULAR MEDICINE REPORTS (2017)
Bufalin attenuates cancer-induced pain and bone destruction in a model of bone cancer
Dongxing Ji et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2017)
Bufalin reverses acquired drug resistance by inhibiting stemness in colorectal cancer cells
Jian Sun et al.
ONCOLOGY REPORTS (2017)
Bufadienolides from amphibians: A promising source of anticancer prototypes for radical innovation, apoptosis triggering and Na+/K+-ATPase inhibition
Livia Queiroz De Sousa et al.
TOXICON (2017)
Radiosynthesis and pharmacokinetics of [18F]fluoroethyl bufalin in hepatocellular carcinoma-bearing mice
Zhaoshuo Yang et al.
ONCOTARGETS AND THERAPY (2017)
Bufalin sensitizes human bladder carcinoma cells to TRAIL-mediated apoptosis
Kyung-Hwa Kang et al.
ONCOLOGY LETTERS (2017)
Bufalin reverses ABCB1-mediated drug resistance in colorectal cancer
Ze-Ting Yuan et al.
ONCOTARGET (2017)
Bufalin Inhibits Cellular Proliferation and Cancer Stem Cell-Like Phenotypes via Upregulation of MiR-203 in Glioma
Tao Liu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Bufalin enhances radiosensitivity of glioblastoma by suppressing mitochondrial function and DNA damage repair
Xin Zhang et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Degradation of Mcl-1 through GSK-3β Activation Regulates Apoptosis Induced by Bufalin in Non-Small Cell Lung Cancer H1975 Cells
Xiao-hong Kang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
The effect and mechanism of bufalin on regulating hepatocellular carcinoma cell invasion and metastasis via Wnt/beta-catenin signaling pathway
Ji Qin Gai et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Identification of the hydroxylated derivatives of bufalin: phase I metabolites in rats
Xiu-Lan Xin et al.
JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH (2016)
Bufalin induces apoptosis in the U-2OS human osteosarcoma cell line via triggering the mitochondrial pathway
Ya Chen et al.
MOLECULAR MEDICINE REPORTS (2016)
Inhibition of SRC-3 enhances sensitivity of human cancer cells to histone deacetylase inhibitors
Zhengzhi Zou et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Bufalin Inhibits hTERT Expression and Colorectal Cancer Cell Growth by Targeting CPSF4
Ningning Zhang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2016)
Traditional Chinese Medicine treatment as maintenance therapy in advanced non-small-cell lung cancer: A randomized controlled trial
Yi Jiang et al.
COMPLEMENTARY THERAPIES IN MEDICINE (2016)
Bufalin enhances anti-angiogenic effect of sorafenib via AKT/VEGF signaling
Haiyong Wang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Inhibitory effect of bufalin combined with Hedgehog signaling pathway inhibitors on proliferation and invasion and metastasis of liver cancer cells
Xia Sheng et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Polymeric prodrug of bufalin for increasing solubility and stability: Synthesis and anticancer study in vitro and in vivo
Tao Liu et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2016)
Knockdown of Apolipoprotein E Enhanced Sensitivity of Hep3B Cells to Cardiac Steroids via Regulating Na+/K+-ATPase Signalosome
Miao Liu et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Bufalin suppresses cancer stem-like cells in gemcitabine-resistant pancreatic cancer cells via Hedgehog signaling
Haiyong Wang et al.
MOLECULAR MEDICINE REPORTS (2016)
Bufalin reverses intrinsic and acquired drug resistance to cisplatin through the AKT signaling pathway in gastric cancer cells
Hongyan Zhao et al.
MOLECULAR MEDICINE REPORTS (2016)
Possible target-related proteins and signal network of bufalin in A549 cells suggested by both iTRAQ-based and label-free proteomic analysis
Dong-Mei Zhang et al.
PROTEOMICS (2016)
Bufalin enhances antitumor effect of paclitaxel on cervical tumorigenesis via inhibiting the integrin α2/β5/FAK signaling pathway
Fei Liu et al.
ONCOTARGET (2016)
Bufalin suppresses hepatocellular carcinoma invasion and metastasis by targeting HIF-1α via the PI3K/AKT/mTOR pathway
Haiyong Wang et al.
ONCOTARGET (2016)
Bufalin Inhibits NCI-H460 Human Lung Cancer Cell Metastasis In Vitro by Inhibiting MAPKs, MMPs, and NF-κB Pathways
Shin-Hwar Wu et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2015)
Bufalin Inhibits the Differentiation and Proliferation of Cancer Stem Cells Derived from Primary Osteosarcoma Cells through Mir-148a
Yuewen Chang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
Bufalin inhibits TGF-β-induced epithelial-to-mesenchymal transition and migration in human lung cancer A549 cells by downregulating TGF-β receptors
Lei Zhao et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2015)
Bufalin Reverses Resistance to Sorafenib by Inhibiting Akt Activation in Hepatocellular Carcinoma: The Role of Endoplasmic Reticulum Stress
Bo Zhai et al.
PLOS ONE (2015)
Steroid Receptor Coactivator-3 (SRC-3/AIB1) as a Novel Therapeutic Target in Triple Negative Breast Cancer and Its Inhibition with a Phospho-Bufalin Prodrug
Xianzhou Song et al.
PLOS ONE (2015)
Bufalin Inhibits HCT116 Colon Cancer Cells and Its Orthotopic Xenograft Tumor in Mice Model through Genes Related to Apoptotic and PTEN/AKT Pathways
Jie Wang et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2015)
Bufalin Inhibits Migration and Invasion in Human Hepatocellular Carcinoma SK-Hep1 Cells Through the Inhibitions of NF-kB and Matrix Metalloproteinase-2/-9-Signaling Pathways
Ya-Yin Chen et al.
ENVIRONMENTAL TOXICOLOGY (2015)
Bufalin Induces Cell Death in Human Lung Cancer Cells through Disruption of DNA Damage Response Pathways
Shin-Hwar Wu et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2014)
Bufalin enhances TRAIL-induced apoptosis by redistributing death receptors in lipid rafts in breast cancer cells
Shunchao Yan et al.
ANTI-CANCER DRUGS (2014)
Blocking autophagy enhances the apoptosis effect of bufalin on human hepatocellular carcinoma cells through endoplasmic reticulum stress and JNK activation
Fengli Hu et al.
APOPTOSIS (2014)
Bufalin Is a Potent Small-Molecule Inhibitor of the Steroid Receptor Coactivators SRC-3 and SRC-1
Ying Wang et al.
CANCER RESEARCH (2014)
Bufalin-Inhibited Migration and Invasion in Human Osteosarcoma U-2 OS Cells Is Carried Out by Suppression of the Matrix Metalloproteinase-2, ERK, and JNK Signaling Pathways
Fu-Shin Chueh et al.
ENVIRONMENTAL TOXICOLOGY (2014)
Bufalin loaded biotinylated chitosan nanoparticles: An efficient drug delivery system for targeted chemotherapy against breast carcinoma
Xin Tian et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2014)
Bufalin Induces the Interplay between Apoptosis and Autophagy in Glioma Cells through Endoplasmic Reticulum Stress
Shuying Shen et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2014)
Bufalin attenuates the stage and metastatic potential of hepatocellular carcinoma in nude mice
Zhou-Ji Zhang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
Anti-Inflammatory and Antinociceptive Activities of Bufalin in Rodents
Lili Wen et al.
MEDIATORS OF INFLAMMATION (2014)
Reversal effect of bufalin on multidrug resistance in human hepatocellular carcinoma BEL-7402/5-FU cells
Wei Gu et al.
ONCOLOGY REPORTS (2014)
Bufalin inhibits the differentiation and proliferation of human osteosarcoma cell line hMG63-derived cancer stem cells
Yuewen Chang et al.
TUMOR BIOLOGY (2014)
MicroRNA-497 and bufalin act synergistically to inhibit colorectal cancer metastasis
Yan-yan Qiu et al.
TUMOR BIOLOGY (2014)
Bufalin, a component in Chansu, inhibits proliferation and invasion of hepatocellular carcinoma cells
Dong-Ze Qiu et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2013)
MiR-181a contributes to bufalin-induced apoptosis in PC-3 prostate cancer cells
Xiao-feng Zhai et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2013)
Cardiac glycosides block cancer growth through HIF-1-and NF-B-mediated Plk1
Chuan-Ming Xie et al.
CARCINOGENESIS (2013)
Anticancer Effects of Bufalin on Human Hepatocellular Carcinoma HepG2 Cells: Roles of Apoptosis and Autophagy
Qing Miao et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Bufalin prevents the migration and invasion of T24 bladder carcinoma cells through the inactivation of matrix metalloproteinases and modulation of tight junctions
Su Hyun Hong et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Bufalin induces G2/M phase arrest and triggers autophagy via the TNF, JNK, BECN-1 and ATG8 pathway in human hepatoma cells
Chin-Mu Hsui et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Traditional herbal medicine in preventing recurrence after resection of small hepatocellular carcinoma: a multicenter randomized controlled trial
Xiao-feng Zhai et al.
JOURNAL OF INTEGRATIVE MEDICINE-JIM (2013)
Bufalin Induces the Apoptosis of Acute Promyelocytic Leukemia Cells via the Downregulation of Survivin Expression
Zhitu Zhu et al.
ACTA HAEMATOLOGICA (2012)
Prospective randomised evaluation of traditional Chinese medicine combined with chemotherapy: a randomised phase II study of wild toad extract plus gemcitabine in patients with advanced pancreatic adenocarcinomas
Z. Meng et al.
BRITISH JOURNAL OF CANCER (2012)
Induction of cytochrome P450 3A by Shexiang Baoxin Pill and its main components
Bo Jiang et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2012)
Bufalin Induces Lung Cancer Cell Apoptosis via the Inhibition of PI3K/Akt Pathway
Zhitu Zhu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
AKT serine/threonine protein kinase modulates bufalin-triggered intrinsic pathway of apoptosis in CAL 27 human oral cancer cells
Shih-Chang Tsai et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
Bufalin increases sensitivity to AKT/mTOR-induced autophagic cell death in SK-HEP-1 human hepatocellular carcinoma cells
Shih-Chang Tsai et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
Down-regulation of Cbl-b by bufalin results in up-regulation of DR4/DR5 and sensitization of TRAIL-induced apoptosis in breast cancer cells
Shunchao Yan et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2012)
Bufalin enhances the anti-proliferative effect of sorafenib on human hepatocellular carcinoma cells through downregulation of ERK
Yang Gao et al.
MOLECULAR BIOLOGY REPORTS (2012)
Bufalin induces G0/G1 phase arrest through inhibiting the levels of cyclin D, cyclin E, CDK2 and CDK4, and triggers apoptosis via mitochondrial signaling pathway in T24 human bladder cancer cells
Wen-Wen Huang et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2012)
Critical Role of Heat Shock Protein 27 in Bufalin-Induced Apoptosis in Human Osteosarcomas: A Proteomic-Based Research
Xian-biao Xie et al.
PLOS ONE (2012)
Inhibition of Jak-STAT3 pathway enhances bufalin-induced apoptosis in colon cancer SW620 cells
Zhitu Zhu et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2012)
Bufalin enhances the antitumor effect of gemcitabine in pancreatic cancer
Ying Chen et al.
ONCOLOGY LETTERS (2012)
Bufadienolide compounds sensitize human breast cancer cells to TRAIL-induced apoptosis via inhibition of STAT3/Mcl-1 pathway
Yinhui Dong et al.
APOPTOSIS (2011)
Bufalin and cinobufagin induce apoptosis of human hepatocellular carcinoma cells via Fas- and mitochondria-mediated pathways
Fanghua Qi et al.
CANCER SCIENCE (2011)
Bufalin induces autophagy-mediated cell death in human colon cancer cells through reactive oxygen species generation and JNK activation
Chuan-Ming Xie et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
Bufalin inhibits CYP3A4 activity in vitro and in vivo
Hai-yun Li et al.
ACTA PHARMACOLOGICA SINICA (2009)
Pilot Study of Huachansu in Patients With Hepatocellular Carcinoma, Nonsmall-Cell Lung Cancer, or Pancreatic Cancer
Zhiqiang Meng et al.
CANCER (2009)
Increased nuclear expression and transactivation of vitamin D receptor by the cardiotonic steroid bufalin in human myeloid leukemia cells
Yusuke Amano et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2009)
Apoptotic signaling in bufalin- and cinobufagin-treated androgen-dependent and -independent human prostate cancer cells
Ching-Han Yu et al.
CANCER SCIENCE (2008)
Efficacy and safety of gemcitabine-oxaliplatin combined with huachansu in patients with advanced gallbladder carcinoma
Tian-Jie Qin et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Anti-tumor activities and apoptosis-regulated mechanisms of bufalin on the orthotopic transplantation tumor model of human hepatocellular carcinoma in nude mice
Ke-Qi Han et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Bufalin induces apoptosis in human osteosarcoma U-2OS and U-2OS methotrexate300-resistant cell lines
Jun-qiang Yin et al.
ACTA PHARMACOLOGICA SINICA (2007)
Determination of bufalin-like immunoreactivity in serum of humans and rats by time-resolved fluoroimmunoassay for using a monoclonal antibody
M Oda et al.
LIFE SCIENCES (2001)
Share Paper
